The Committee meets on the second and fourth Tuesday of each month.

The first of these meetings is used to evaluate:

  • Modifications to trials (Royal Decree 561/1993)
  • Observational studies
  • Clinical-research projects
  • Letters and reports
  • Adverse events

The second of these meetings is used to evaluate:

  • New clinical trials (Royal Decree 223/2004)
  • Single-center clinical trials
  • Clinical trials using medicinal products

Material and non-material modifications to clinical trials (Royal Decree 223/2004)